Stiefel Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Stiefel Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stiefel Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Stiefel Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
23 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Stiefel Laboratories, Inc. (Stiefel Laboratories), a subsidiary of GlaxoSmithKline Plc is a skincare pharmaceutical company that focuses on the skin health. The company develops products for sun care, dry skin and clear skin. It also offers research and development, manufacture, marketing and distribution of prescription medications, over-the-counter (OTC) products and signature products for the treatment of a range of dermatology conditions. Stiefel Laboratories provides treatment of a variety of dermatological ailments such as acne, atopic dermatitis, psoriasis, eczema, soriatane, seborrheic dermatitis, and various forms of dermatoses.

Stiefel Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed informa

  
Source:
Document ID
GDPH6328D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Stiefel Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Stiefel Laboratories, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Stiefel Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Stiefel Laboratories, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Stiefel Laboratories, Inc., Medical Devices Deals, 2010 to YTD 201691
Stiefel Laboratories, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Stiefel Laboratories, Inc., Pharmaceuticals &Healthcare, Deal Details119
  Asset Purchase111
    Stiefel Labs Acquires WBI-1001 From Welichem Biotech For US$34 Million112
  Partnerships131
    DUSA Pharma Terminates Marketing, Distribution and Supply Agreement with Stiefel Labs131
  Licensing Agreements141
    Basilea Pharmaceutica Amends Terms of Licensing Agreement with Stiefel Labs for Toctino142
  Asset Transactions161
    Almirall Acquires Rights to Veltin and Altabax from Stiefel161
    Aqua Pharma Acquires US Rights To Verdeso Foam From Stiefel171
    Merz Pharma Acquires Onmel From Stiefel Labs181
    Aqua Pharma Acquires XOLEGEL, Topical Treatment Of Seborrheic Dermatitis, From Stiefel Labs191
Stiefel Laboratories, Inc. - Key Competitors201
Key Employees211
Locations And Subsidiaries221
  Head Office221
Appendix231
  Methodology231
  About GlobalData231
  Contact Us231
  Disclaimer231

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Stiefel Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stiefel-Laboratories-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10138>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Stiefel Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stiefel-Laboratories-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10138>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research